Building the Perfect Antibody-based Therapeutic from Selection to Engineering and Manufacturing

Guest Speaker

Linglan Fu, Ph.D.

Associate Scientist
Zymeworks

Eason Lin, Ph.D.

Senior Scientist
AurekaBio

Peter Hsueh, Ph.D.

Marketing Product Manager
ACROBiosystems

Overview

In this webinar, discover how advanced techniques such as Al-driven candidate selection optimization of antibody sequences, and precise conjugation methods come together to address some of the current challenges in antibody-based therapeutics.

Some things you’ll learn include:

- Antibody Engineering with Zymeworks: Learn about how we push the boundary of antibody engineering by optimizing antibody sequences to develop the next generation of antibody-based therapeutics, including antibody-drug conjugates.

- Strategic Al-based Antibody Selection with Aureka Bio: Learn about how Al can accelerate the selection, synthesis, and characterization of antibody candidates at scale during therapeutic discovery.

- Precision in Antibody Conjugation with ACROBiosystems: Discover how ACROBiosystems can transform your antibodies into antibody-drug conjugates with various life science tools to conjugate and characterize your ADC.

Resource download

Organisers